Idelalisib Tablet — FDA Drug Shortage

To Be Discontinued — Gilead Sciences, Inc.

The FDA lists a drug shortage record for Idelalisib Tablet (tablet) from Gilead Sciences, Inc. with status To Be Discontinued. The shortage was first posted on 04/07/2026.

Shortage Details

Status
To Be Discontinued
Company
Gilead Sciences, Inc.
Package NDC
61958-1701-1
Dosage Form
Tablet
Presentation
Zydelig, Tablet, 100 mg (NDC 61958-1701-1)
Initial Posting
04/07/2026
Revised Date